ESC 365 - Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

EHRA Premium Access

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Session: ePosters Day 2

Topic: Mechanisms for Stroke

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Event: EHRA 2022

Congress Session

About the speaker

Doctor Luca Sgarra

Regional General Hospital F. Miulli, Acquaviva Delle Fonti (Italy)

0 follower

131 more presentations in this session

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhya, UA)

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Incidence and exploratory analysis of cancer development after new on-set atrial fibrillation

Speaker: Doctor F. Quesada Ocete (Valencia, ES)

Access the full session

ePosters Day 2

Speakers: Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic, Doctor A. Aro...

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

Related content

EHRA Premium Access

Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation

5 April 2022

EHRA Premium Access

Left ventricular septal pacing: how deep is enough?

5 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

This platform is supported by